Book a Meeting

Fc Engineered Anti-Human CD23 Antibody, CDC-Enhanced (CAT#: Biobet-C115ZP) Datasheet

Target
CD23
Isotype
Human IgG1, κ
Description
Fc Engineered Anti-Human CD23 Antibody, CDC-Enhanced (Biobet-C115ZP) is a recombinant monoclonal Human IgG1, κ antibody against CD23. This product is a CDC enhanced antibody produced by our proprietary platform.
Indication
Allergic asthma
Classification
Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced rituximab. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
CD23
Gene ID
UniProt ID
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
Human IgG1, κ
Indication
Allergic asthma

Allergic asthma

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany

ISO 9001 Certified - Creative Biolabs Quality Management System.